Home › NDC Lookup › RxCUI directory › RxCUI 1796424

2 ML pralatrexate 20 MG/ML Injection — RxCUI 1796424

Name: 2 ML pralatrexate 20 MG/ML Injection (RxCUI 1796424)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1796424 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1796424

Official name2 ML pralatrexate 20 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known aspralatrexate 40 MG per 2 ML Injection; PRALAtrexate 40 MG in 2 ML Injection

FDA products mapped6

Package NDCs mapped6

Reported Medicaid activity (SDUD)86 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pralatrexate Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Pralatrexate injection is a chemotherapy used specifically for peripheral T-cell lymphoma — a type of blood cancer affecting T-cells — when it has come back after treatment or stop...
These supplements are really important — they help protect your body from some of pralatrexate's most serious side effects, especially mouth sores and low blood counts. You need to...
Why do I have to take folic acid and vitamin B12 before my infusions?
The ones to act on immediately are: severe or worsening mouth sores that make it hard to eat or drink, signs of infection like fever or chills (which can signal dangerously low whi...

📖 Read our full Pralatrexate Injection guide →

🕸️ Concept Web — How 2 ML pralatrexate 20 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 2 ML pralatrexate 20 MG/ML Injection RxCUI 1796424 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Pralatrexate 662019 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Folotyn 865180 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Pralatrexate Injection 1796418 SCDF
- Pralatrexate Injectable Product 1161096 SCDG
- Pralatrexate Injection [Folotyn] 1796420 SBDF
- Folotyn Injectable Product 1172604 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Pralatrexate 20 MG/ML 865177 SCDC
- 2 ML pralatrexate 20 MG/ML Injection [Folotyn] 1796425 SBD
- Pralatrexate 20 MG/ML [Folotyn] 865181 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Pralatrexate 20 MG/ML SCDC · 865177
Pralatrexate Injection SCDF · 1796418
Pralatrexate Injectable Product SCDG · 1161096

Brand-Name Concepts

2 ML pralatrexate 20 MG/ML Injection [Folotyn] SBD · 1796425
Pralatrexate 20 MG/ML [Folotyn] SBDC · 865181
Pralatrexate Injection [Folotyn] SBDF · 1796420
Folotyn Injectable Product SBDG · 1172604
Folotyn BN · 865180

📦 FDA Products & Package NDCs

6 products · 6 package NDCs

6 package NDCs map to RxCUI 1796424 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
43598-0342-11	1 VIAL, SINGLE-DOSE in 1 CARTON (43598-342-11) / 1 mL in 1...	Pralatrexate	Dr.Reddy's Laboratories Inc.,	2026-03-04
43598-0343-23	1 VIAL, SINGLE-DOSE in 1 CARTON (43598-343-23) / 2 mL in 1...	Pralatrexate	Dr.Reddy's Laboratories Inc.,	2026-03-04
65219-0550-01	1 VIAL, SINGLE-DOSE in 1 CARTON (65219-550-01) / 1 mL in 1...	Pralatrexate	Fresenius Kabi USA, LLC	2022-11-15
65219-0552-02	1 VIAL, SINGLE-DOSE in 1 CARTON (65219-552-02) / 2 mL in 1...	Pralatrexate	Fresenius Kabi USA, LLC	2022-11-15
72893-0003-01	1 VIAL in 1 CARTON (72893-003-01) / 1 mL in 1 VIAL	Folotyn	Acrotech Biopharma Inc	2009-09-24
72893-0005-01	1 VIAL in 1 CARTON (72893-005-01) / 2 mL in 1 VIAL	Folotyn	Acrotech Biopharma Inc	2009-09-24

Observed labelers: Acrotech Biopharma Inc (2) · Dr.Reddy's Laboratories Inc., (2) · Fresenius Kabi USA, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9307	Pralatrexate injection	6	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.